Skip To Main Content
Sasa Pockar on Muck Rack

Sasa Pockar

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sasa

Contact Sasa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies

|
By Amelia Rees, Jessy Choi, Clare Nash, Daniel Hawley, Vinod Sharma, Alice Chieng, Jane Ashworth, Raheej Khan, Sasa Pockar, Shiao Wei Wong, Guilia Varnier
| Nature Verified
Abstract Adalimumab (ADA) is a well-established treatment for refractory paediatric uveitis; however, some patients remain inadequately controlled on standard biweekly dosing. Weekly ADA injections are increasingly used, though evidence in paediatric cohorts remains limited. This study evaluates outcomes of escalation to weekly ADA in children with refractory uveitis and explores the relevance of serum drug levels and anti-ADA antibodies (AAA).
Open in Who Shared Issue with article?
See all 1 articles